TCR-pMHC Binding Changes From Tumor Mutations

ISEF Category: Cellular and Molecular Biology

Subcategory: Cellular Immunology  ·  Difficulty: Advanced  ·  Setup: University Lab  ·  Time: Full Year

The Hook

A single amino acid change can help a tumor hide from your immune system. That tiny swap can change how long a T cell receptor stays attached to its target. If the bond breaks faster, the immune signal may fade. You can study that with molecular dynamics and binding data.

What Is It?

T cells patrol your body with receptors called TCRs, short for T cell receptors. These receptors grab onto pieces of proteins displayed on cell surfaces by pMHC, short for peptide-major histocompatibility complex. If the fit is strong enough, the T cell can react. If the fit is weak, the signal may disappear before the T cell fully responds.

Think of the TCR and pMHC like a hand and a knob. The shape matters, but so does how long the hand stays on the knob. Molecular dynamics lets you simulate how the atoms move over time, so you can estimate whether a mutation makes the bond looser or tighter. In this project, you would test a published neoantigen, then ask how single-residue tumor mutations change the off-rate, which is how fast the complex falls apart.

IEDB, the Immune Epitope Database, can help you compare your predictions to known binding data. That makes the project more than a simulation exercise. You get to connect molecular motion with a real immune outcome.

Why This Is a Good Topic

This topic works well because you can change one amino acid at a time and measure a clear outcome, like predicted binding stability or off-rate. It connects to cancer immunology, which gives the project real-world stakes. You can also compare your model to published data, so your work is testable instead of purely descriptive. A strong student can learn structural biology, basic immunology, data analysis, and how to judge whether a model matches reality.

Research Questions

• How does a single-residue tumor mutation change the predicted off-rate of a TCR-pMHC complex?
• What is the effect of mutation position on the stability of the TCR-pMHC interface?
• Does the predicted binding change match known IEDB binding trends for related neoantigens?
• To what extent do changes in hydrogen bonding predict changes in off-rate for the mutant complexes?
• Which mutant residues cause the largest shift in interface contact persistence during simulation?
• How does the wild-type neoantigen compare with multiple mutant versions in predicted immune recognition?

Basic Materials

• A computer with enough memory to run molecular dynamics software or access to a university computing cluster.
• A published TCR-pMHC complex structure from the Protein Data Bank.
• A list of neoantigen sequences and single-residue variants.
• IEDB access for binding and epitope comparison.
• A text editor for preparing input files and notes.
• A spreadsheet program for organizing simulation outputs and metadata.
• A basic statistics tool for comparing replicates and ranking mutants.

Advanced Materials

• A workstation or cluster node with a GPU or high-memory CPU access.
• Molecular dynamics software such as GROMACS, AMBER, or NAMD.
• Structure preparation tools for protonation, missing atoms, and mutations.
• PyMOL or UCSF ChimeraX for interface inspection.
• Trajectory analysis tools for contact maps, RMSD, and hydrogen bonds.
• Access to protein structure prediction or docking tools for sensitivity checks.
• A version control system for tracking input files, scripts, and analysis steps.

Software & Tools

• GROMACS: Runs molecular dynamics simulations and generates trajectories for TCR-pMHC complexes.
• PyMOL: Visualizes interface contacts, mutation sites, and structural changes.
• UCSF ChimeraX: Helps inspect protein structures and compare wild-type and mutant models.
• Python: Automates analysis, plotting, and comparison of simulation outputs.
• R: Supports statistics, summary plots, and significance testing across mutants.

Experiment Steps

1. Choose one published TCR-pMHC structure and define the exact interface region you will study.
2. Select a small set of single-residue mutations that represent realistic tumor changes, then justify why each one might alter binding.
3. Build a comparison plan that keeps the protein backbone and analysis method consistent across wild-type and mutant systems.
4. Decide which outputs will define your main signal, such as contact persistence, hydrogen bonding, or estimated off-rate.
5. Set up a validation strategy that compares your simulation ranking with IEDB or other published binding data.
6. Plan how you will test whether your result stays the same across replicate runs and alternative analysis choices.

Common Pitfalls

• Changing too many residues at once, which makes it impossible to tell which mutation caused the binding shift.
• Treating a single simulation run as proof, which ignores random motion and gives unstable conclusions.
• Comparing mutants built from different structural templates, which mixes mutation effects with model-preparation artifacts.
• Focusing only on one output metric, which can hide cases where contact counts, hydrogen bonds, and off-rate point in different directions.
• Using IEDB as a direct match instead of a comparison source, which can lead you to compare your model to the wrong assay type or epitope context.

What Makes This Competitive

A strong version of this project does more than report one simulation result. You would compare several mutants, use replicate runs, and test whether your rankings hold across more than one analysis metric. You could also separate structural stability from binding behavior, then ask which feature best predicts the off-rate. That kind of careful modeling and validation makes the project much stronger.

Project Variations

• Study a different published neoantigen from the same cancer type and compare how mutation location changes predicted escape.
• Swap molecular dynamics for a docking-plus-scoring workflow, then test whether the simpler model agrees with the full simulation ranking.
• Add an analysis of peptide flexibility or solvent exposure to see whether motion outside the interface helps predict off-rate.

Learn More

• IEDB: Search the Immune Epitope Database for published binding assays, neoantigens, and TCR recognition data.
• RCSB Protein Data Bank: Find TCR-pMHC complex structures and structural metadata for your starting model.
• NCBI PubMed: Search for review articles on TCR recognition, neoantigens, and pMHC binding kinetics.
• NIH Molecular Dynamics Tutorials: Search NIH and university-hosted tutorials for protein simulation setup and analysis basics.
• MIT OpenCourseWare: Find free structural biology and immunology course materials for background on protein binding and immune recognition.